|
 |
 |
|
Board of Directors
LineGen's Board of Directors is comprised of experienced and successful biotechnology industry leaders and scientists. |
| |
|
|
 |
| Stephen M. Prescott, M.D. |
|
| President, Oklahoma Medical Research Foundation |
|
| |
|
| Dr. Prescott became president of the Oklahoma Medical Research Foundation (OMFR) in the spring of 2006. A global leader in studies...Click here to read more |
|
| |
|
| |
|
 |
| Fred Middleton |
|
| Managing Director, Sanderling Ventures |
|
| |
|
| Fred Middleton has more than twenty-eight years experience in the biotechnology and biomedical industries, both in corporate management and... Click here to read more |
|
| |
|
| |
|
 |
| Dinesh Patel, Ph.D. |
|
| Managing Director, vSpring Capital |
|
| |
|
| Dr. Patel is a founding managing director of vSpring Capital. From 1999 to 2004 he was the Founder, Chairman, President & CEO of Ashni Naturaceuticals... Click here to read more |
|
| |
|
| |
|
 |
| Daniel C. Wood, CFA |
|
| General Partner, Mesa Verde Venture Partners |
|
| |
|
| Daniel C. Wood, CFA, is general partner of Mesa Verde Venture Partners, an early-stage bioscience venture capital fund focused on the Southwestern... Click here to read more |
|
| |
|
| |
|
 |
| Al R. Harris, Ph.D. |
|
| Director |
|
| |
|
| Al Harris has over twenty years of experience in business negotiation and licensing. He has initiated, negotiated, and completed more that 400 deals. |
|
| |
|
|
